Orr et al. [27] demonstrated that elevated nuclear immunoreactivity of YAP1 was prominent in high-grade gliomas, suggesting the potential role of YAP1 in the pathobiology of the most common malignant brain tumors. This evidence concerns the gene YAP1 and central nervous system cancer.